Extended hormone therapy may help some women with ER+ breast cancer

[News]

Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five.

More... (http://www.medicalnewstoday.com/releases/274300.php)